Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / BIOTECH ETF
-
Number of holders
-
96
-
Total 13F shares, excl. options
-
742K
-
Shares change
-
-68.9K
-
Total reported value, excl. options
-
$114M
-
Value change
-
-$10.6M
-
Put/Call ratio
-
2.33
-
Number of buys
-
24
-
Number of sells
-
-39
-
Price
-
$153.28
Significant Holders of VANECK ETF TRUST - BIOTECH ETF (BBH) as of Q2 2025
115 filings reported holding BBH - VANECK ETF TRUST - BIOTECH ETF as of Q2 2025.
VANECK ETF TRUST - BIOTECH ETF (BBH) has 96 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 742K shares
.
Largest 10 shareholders include GOLDMAN SACHS GROUP INC (110K shares), Miller Investment Management, LP (81.4K shares), RAYMOND JAMES FINANCIAL INC (67.9K shares), TD Waterhouse Canada Inc. (64.7K shares), BANK OF AMERICA CORP /DE/ (52.5K shares), MORGAN STANLEY (31.3K shares), WELLS FARGO & COMPANY/MN (27.5K shares), LPL Financial LLC (22.3K shares), UBS Group AG (21.2K shares), and Royal Bank of Canada (19K shares).
This table shows the top 96 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.